Literature DB >> 27707777

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

P Malfertheiner1, F Megraud2, C A O'Morain3, J P Gisbert4,5, E J Kuipers6, A T Axon7, F Bazzoli8, A Gasbarrini9, J Atherton10, D Y Graham11, R Hunt12,13, P Moayyedi14, T Rokkas15, M Rugge16, M Selgrad17, S Suerbaum18, K Sugano19, E M El-Omar20.   

Abstract

Important progress has been made in the management of Helicobacter pylori infection and in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role of H. pylori were re-evaluated in 2015. In the Maastricht V/Florence Consensus Conference, 43 experts from 24 countries examined new data related to H. pylori in five subdivided workshops: (1) Indications/Associations, (2) Diagnosis, (3) Treatment, (4) Prevention/Public Health, (5) H. pylori and the Gastric Microbiota. The results of the individual workshops were presented to a final consensus voting that included all participants. Recommendations are provided on the basis of the best available evidence and relevance to the management of H. pylori infection in the various clinical scenarios. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  GASTRITIS; HELICOBACTER PYLORI; HELICOBACTER THERAPY

Mesh:

Substances:

Year:  2016        PMID: 27707777     DOI: 10.1136/gutjnl-2016-312288

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  626 in total

1.  MEK Inhibitor Reverses Metaplasia and Allows Re-Emergence of Normal Lineages in Helicobacter pylori-Infected Gerbils.

Authors:  Qing Yang; Tomohiko Yasuda; Eunyoung Choi; Takeshi Toyoda; Joseph T Roland; Eiji Uchida; Hiroshi Yoshida; Yasuyuki Seto; James R Goldenring; Sachiyo Nomura
Journal:  Gastroenterology       Date:  2018-11-02       Impact factor: 22.682

2.  Chemoprevention of gastric cancer development after Helicobacter pylori eradication therapy in an East Asian population: Meta-analysis.

Authors:  Mitsushige Sugimoto; Masaki Murata; Yoshio Yamaoka
Journal:  World J Gastroenterol       Date:  2020-04-21       Impact factor: 5.742

3.  Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial.

Authors:  Ping-I Hsu; Feng-Woei Tsai; Sung-Shuo Kao; Wen-Hung Hsu; Jin-Shiung Cheng; Nan-Jing Peng; Kuo-Wang Tsai; Huang-Ming Hu; Yao-Kuang Wang; Seng-Kee Chuah; Angela Chen; Deng-Chyang Wu
Journal:  Am J Gastroenterol       Date:  2017-07-18       Impact factor: 10.864

4.  Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization.

Authors:  Amin Talebi Bezmin Abadi
Journal:  World J Gastroenterol       Date:  2017-09-21       Impact factor: 5.742

Review 5.  Diagnosis of Helicobacter pylori infection : A short review.

Authors:  Ante Tonkic; Jonatan Vukovic; Pavle Vrebalov Cindro; Valdi Pesutic Pisac; Marija Tonkic
Journal:  Wien Klin Wochenschr       Date:  2018-06-29       Impact factor: 1.704

Review 6.  Dealing with uncertainty in the treatment of Helicobacter pylori.

Authors:  Xavier Calvet
Journal:  Ther Adv Chronic Dis       Date:  2018-02-12       Impact factor: 5.091

7.  Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Helicobacter pylori Infection in the Dominican Republic.

Authors:  Muhammad Miftahussurur; Modesto Cruz; Phawinee Subsomwong; José A Jiménez Abreu; Celso Hosking; Hiroyuki Nagashima; Junko Akada; Yoshio Yamaoka
Journal:  Am J Trop Med Hyg       Date:  2017-02-13       Impact factor: 2.345

8.  Histopathology Findings in Patients Undergoing Laparoscopic Sleeve Gastrectomy.

Authors:  Ammiel Martínez Canil; Angelo Iossa; Pietro Termine; Daniela Caporilli; Vincenzo Petrozza; Gianfranco Silecchia
Journal:  Obes Surg       Date:  2018-06       Impact factor: 4.129

9.  A Novel Stool PCR Test for Helicobacter pylori May Predict Clarithromycin Resistance and Eradication of Infection at a High Rate.

Authors:  Erin Beckman; Ilaria Saracino; Giulia Fiorini; Courtney Clark; Vladimir Slepnev; Denise Patel; Clarissa Gomez; Reddy Ponaka; Vecheslav Elagin; Dino Vaira
Journal:  J Clin Microbiol       Date:  2017-05-17       Impact factor: 5.948

10.  Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States.

Authors:  Hashem B El-Serag; John Y Kao; Fasiha Kanwal; Mark Gilger; Frank LoVecchio; Steven F Moss; Sheila E Crowe; Adam Elfant; Thomas Haas; Ronald J Hapke; David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-17       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.